A comparison of telavancin and vancomycin for treatment of methicillin-resistant Staphylococcus aureus infections: A meta-analysis

Telavancin is a reliable alternative to vancomycin in the treatment of MRSA-confirmed infections despite the incidence of serious adverse events. The potential for telavancin-induced serious adverse events and nephrotoxicity should be taken into consideration before treatment. .